BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 28559119)

  • 1. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
    Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
    Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma.
    Zhuang J; Wang S; Wang Y; Wu Y; Hu R
    BMC Cancer; 2024 May; 24(1):568. PubMed ID: 38714979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma.
    Gao Y; Wang M; Guo X; Hu J; Chen TM; Finn SMB; Lacy J; Kunstman JW; Cha CH; Bellin MD; Robert ME; Desir GV; Gorelick FS
    PLoS One; 2021; 16(9):e0250539. PubMed ID: 34587190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival.
    Achalandabaso Boira M; Di Martino M; Gordillo C; Adrados M; Martín-Pérez E
    BMC Cancer; 2020 Sep; 20(1):909. PubMed ID: 32967636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic effect of CD73 in pancreatic ductal adenocarcinoma for disease-free survival after radical surgery.
    Qin D; Wei R; Huang K; Wang R; Ding H; Yao Z; Xi P; Li S
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7805-7817. PubMed ID: 37032378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma.
    Khalil L; Huang Z; Zakka K; Jiang R; Penley M; Alese OB; Shaib WL; Wu C; Behera M; Reid MD; El-Rayes BF; Akce M
    Pancreas; 2023 Jan; 52(1):e75-e84. PubMed ID: 37378903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.
    Sweed D; Elhamed SMA; Aiad HAS; Ehsan NA; Hemida AS; Dawoud MM
    World J Surg Oncol; 2024 Mar; 22(1):84. PubMed ID: 38532463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patients.
    Liu W; Huo Y; Yang J; Fu X; Yang M; Tao L; Liu D; Zhang J; Hua R; Sun Y
    Oncol Lett; 2018 Jun; 15(6):9287-9292. PubMed ID: 29844826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BEYOND TRADITIONAL TOOLS: EXPLORING CONVOLUTIONAL NEURAL NETWORKS AS INNOVATIVE PROGNOSTIC MODELS IN PANCREATIC DUCTAL ADENOCARCINOMA.
    Ahmed HS
    Arq Gastroenterol; 2024; 61():e23107. PubMed ID: 38511794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handgrip Strength Predicts Survival in Patients With Pancreatic Cancer.
    Freckelton J; Rajagopalan A; Moore GT; Croagh D
    Pancreas; 2024 May; 53(5):e405-e409. PubMed ID: 38517481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition parameters predict survival in pancreatic cancer-A retrospective multicenter analysis.
    Damm M; Efremov L; Jalal M; Nadeem N; Dober J; Michl P; Wohlgemuth WA; Wadsley J; Hopper AD; Krug S; Rosendahl J
    United European Gastroenterol J; 2023 Dec; 11(10):998-1009. PubMed ID: 37987099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal adenocarcinoma.
    Knipper K; Hussein Y; Simon AG; Fretter C; Damanakis AI; Zhao Y; Bruns CJ; Schmidt T; Popp FC; Quaas A; Lyu SI;
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):137. PubMed ID: 38502354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated tissue expression of RANKL and RANK is associated with poorer survival rates in pancreatic cancer patients.
    Ortega MA; Jiménez-Álvarez L; Fraile-Martinez O; Garcia-Montero C; De León-Oliva D; Toledo-Lobo MDV; Palacios E; Granado P; Esteban A; Guijarro LG; Pekarek L; Asúnsolo Á; López-González L; Bujan J; García-Honduvilla N; Álvarez-Mon M; Saez MA; Díaz-Pedrero R
    Histol Histopathol; 2023 Dec; ():18700. PubMed ID: 38230588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and hotspots of prognostic factors for pancreatic ductal adenocarcinoma from 2013 to 2022.
    Peng J; Lv M; Peng Y; Tang X
    Hepatobiliary Surg Nutr; 2024 Apr; 13(2):370-373. PubMed ID: 38617492
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction Notice to: Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2.
    Morita K; He S; Nowak RP; Wang J; Zimmerman MW; Fu C; Durbin AD; Martel MW; Prutsch N; Gray NS; Fischer ES; Look AT
    Cell; 2022 Aug; 185(16):3058. PubMed ID: 35931023
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis.
    Wang X; Wu S; Chen Y; Shao E; Zhuang T; Lu L; Chen X
    Front Pharmacol; 2020; 11():5. PubMed ID: 32076409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study.
    Lu L; Zhuang T; Shao E; Liu Y; He H; Shu Z; Huang Y; Yao Y; Lin S; Lin S; Chen X; Chen X
    PLoS One; 2019; 14(9):e0221964. PubMed ID: 31504043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients.
    Jia Y; Gao Y; Li J; Chang Z; Yan J; Qin Y
    Onco Targets Ther; 2019; 12():1129-1135. PubMed ID: 30809094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma.
    Yin Y; Zhu X; Huang S; Zheng J; Zhang M; Kong W; Chen Q; Zhang Y; Chen X; Lin K; Ouyang X
    Tumour Biol; 2017 Jun; 39(6):1010428317699131. PubMed ID: 28618924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma.
    Qin H; Li Y; Zhang H; Wang F; He H; Bai X; Li S
    Onco Targets Ther; 2019; 12():1917-1927. PubMed ID: 30881043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.